Mylan gets DCGI approval for anti-TB drug Pretomanid
Mylan, a global pharmaceutical company, today announced that the Drug Controller General of India (DCGI) has approved the anti-tuberculosis drug […]
Say something
Covid-19: Mylan’s remdesivir gets DCGI nod for emergency use
Mylan has announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency […]
Mylan set to launch new TB drug in India after DCGI’s approval
Multinational pharmaceutical company Mylan is working with Drug Controller General of India (DCGI) to launch pretomanid, a medicine used to […]
Mylan to invest $1 billion in India on capex in 6 years
Multinational drug company Mylan has said it will invest $ one billion in the next 5-6 years on Capex in […]
U.S. FDA accepts Biologics License Application for Mylan
Biocon Ltd announced that the U.S.Food and Drug Administration has accepted Mylans biologics license application for MYL- 1401O. Dr Arun […]
Abbott Affirms its Support for Mylan’s proposed acquisition of Perrigo
Abbott, a global healthcare company, has confirmed that it will continue support for Mylan N.V’s growth strategy by stating its […]
Mylan to acquire Abbott business in $5.3B deal
Mylan Inc announced that it has entered into a definitive agreement with Abbott (NYSE: ABT) whereby Mylan will acquire Abbott’s […]
Two Indian Healthcare Companies Jointly Steps in M&A Deals
US-based generic drug maker Mylan Inc is going to pay USD 1.6 billion plus potential additional consideration of up to […]
-
-
Flipkart Health+ App Launched
06-04-2022
